These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9538518)

  • 1. Mining the NCI anticancer drug discovery databases: genetic function approximation for the QSAR study of anticancer ellipticine analogues.
    Shi LM; Fan Y; Myers TG; O'Connor PM; Paull KD; Friend SH; Weinstein JN
    J Chem Inf Comput Sci; 1998; 38(2):189-99. PubMed ID: 9538518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity.
    Shi LM; Myers TG; Fan Y; O'Connor PM; Paull KD; Friend SH; Weinstein JN
    Mol Pharmacol; 1998 Feb; 53(2):241-51. PubMed ID: 9463482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure-antitumor activity relationships of camptothecin analogues: cluster analysis and genetic algorithm-based studies.
    Fan Y; Shi LM; Kohn KW; Pommier Y; Weinstein JN
    J Med Chem; 2001 Sep; 44(20):3254-63. PubMed ID: 11563924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mining and visualizing large anticancer drug discovery databases.
    Shi LM; Fan Y; Lee JK; Waltham M; Andrews DT; Scherf U; Paull KD; Weinstein JN
    J Chem Inf Comput Sci; 2000; 40(2):367-79. PubMed ID: 10761142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern recognition methods investigation of ellipticines structure-activity relationships.
    de Melo LC; Braga SF; Barone PM
    J Mol Graph Model; 2007 Mar; 25(6):912-20. PubMed ID: 17049892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise synthesis and antiproliferative activity evaluation of ellipticine quinone and its analogs.
    Nishiyama T; Hatae N; Mizutani M; Yoshimura T; Kitamura T; Miyano M; Fujii M; Satsuki N; Ishikura M; Hibino S; Choshi T
    Eur J Med Chem; 2017 Aug; 136():1-13. PubMed ID: 28477443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlating gene expression with chemical scaffolds of cytotoxic agents: ellipticines as substrates and inhibitors of MDR1.
    Huang Y; Blower PE; Yang C; Barbacioru C; Dai Z; Zhang Y; Xiao JJ; Chan KK; Sadée W
    Pharmacogenomics J; 2005; 5(2):112-25. PubMed ID: 15668728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
    Ruckdeschel JC; Modi SP; el-Hamouly W; Portuese E; Archer S
    J Med Chem; 1992 Dec; 35(26):4854-7. PubMed ID: 1479585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactivities and Action Mechanisms of Ellipticine Derivatives Reported Prior to 2023.
    Hou W; Xu XL; Huang LJ; Zhang ZY; Zhou ZN; Wang JY; Ouyang X; Xin SY; Zhang ZY; Xiong Y; Huang H; Lan JX
    Chem Biodivers; 2024 May; 21(5):e202400210. PubMed ID: 38433548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and study of 9-substituted ellipticine and 2-methylellipticinium analogues as potential CNS-selective antitumor agents.
    Anderson WK; Gopalsamy A; Reddy PS
    J Med Chem; 1994 Jun; 37(13):1955-63. PubMed ID: 8027977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
    Ahmadi S; Habibpour E
    Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro antitumor activity of novel 2-alkyl-5-methoxycarbonyl-11-methyl-6H-pyrido[4,3-b]carbazol-2-ium and 2-alkylellipticin-2-ium chloride derivatives.
    Mori R; Kato A; Komenoi K; Kurasaki H; Iijima T; Kawagoshi M; Kiran YB; Takeda S; Sakai N; Konakahara T
    Eur J Med Chem; 2014 Jul; 82():16-35. PubMed ID: 24863982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the Antileukemia Activity of Ellipticine-Related Compounds: QSAR and Molecular Docking Study.
    Márquez E; Mora JR; Flores-Morales V; Insuasty D; Calle L
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31861689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro stimulation by ellipticine derivatives of DNA cleavage induced by DNA topoisomerase II: a structure-activity relationship].
    Fossé P; Charra M; Paoletti C; Saucier JM; René B
    Bull Cancer; 1994 Mar; 81(3):194-202. PubMed ID: 7894127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of a series of cytotoxic 2-acyl-1,2-dihydroellipticines which inhibit topoisomerase II.
    Devraj R; Jurayj J; Fernandez JA; Barrett JF; Cushman M
    Anticancer Drug Des; 1996 Jun; 11(4):311-24. PubMed ID: 8679054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ellipticine analogues and related compounds as inhibitors of reverse transcriptase and as inhibitors of the efflux pump.
    Sharples D; Hajós G; Riedl Z; Csányi D; Molnár J; Szabó D
    Arch Pharm (Weinheim); 2001 Sep; 334(8-9):269-74. PubMed ID: 11688136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo.
    Wu Y; Sadatmousavi P; Wang R; Lu S; Yuan YF; Chen P
    Int J Nanomedicine; 2012; 7():3221-33. PubMed ID: 22802684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extending nature's leads: the anticancer agent ellipticine.
    Garbett NC; Graves DE
    Curr Med Chem Anticancer Agents; 2004 Mar; 4(2):149-72. PubMed ID: 15032720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New pyridocarbazole derivatives. Synthesis and their in vitro anticancer activity.
    Jasztold-Howorko R; Tylińska B; Biaduń B; Gebarowski T; Gasiorowski K
    Acta Pol Pharm; 2013; 70(5):823-32. PubMed ID: 24147360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of novel isoellipticine derivatives and salts.
    Miller CM; O'Sullivan EC; Devine KJ; McCarthy FO
    Org Biomol Chem; 2012 Oct; 10(39):7912-21. PubMed ID: 22940706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.